Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: A systematic review

Simple item page
dc.contributor.authorRodrigo, Gustavo Javier
dc.contributor.authorNeffen, Hugo E.
dc.contributor.authorCastro Rodríguez, José Antonio
dc.date.accessioned2022-01-06T13:17:34Z
dc.date.available2022-01-06T13:17:34Z
dc.date.issued2011
dc.fuente.origenORCID
dc.identifier.doi10.1378/chest.10-1194
dc.identifier.issn0012-3692
dc.identifier.urihttps://www.doi.org/10.1378/chest.10-1194
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-78649673636&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/63123
dc.information.autorucEscuela de medicina ; Castro Rodríguez, José Antonio ; 0000-0002-0708-4281 ; 113247
dc.issue.numeroNo. 1
dc.language.isoen
dc.pagina.final35
dc.pagina.inicio28
dc.provenancengjara 2022-01-06 10:17:33
dc.relation.isformatofChest, vol. 139, no. 1 (ene. 2011), pp. 28-35.
dc.revistaChest
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherMedicina y salud
dc.titleEfficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: A systematic review
dc.typeartículo
dc.volumenVol. 139
sipa.codpersvinculados113247
Files
Collections
Artículos de revistas